Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract

Intervirology

Volumn 48, Issue 4, 2005, Pages 207-212

  Chen, Liang ^a   Lin, Tao ^a   Zhang, HongXin ^a   Su, YongBo ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

DNA vaccine; Foot and mouth disease virus; Isatis indigotica

Indexed keywords

DNA VACCINE; FOOT AND MOUTH DISEASE VACCINE; ISATIS INDIGOTICA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADJUVANT CHEMOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ASSAY; CELL ASSAY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; IMMUNIZATION; INJECTION; ISATIS; ISATIS INDIGOTICA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; SWINE; T LYMPHOCYTE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; ISATIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; SWINE; SWINE DISEASES; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS; ISATIS INDIGOTICA;

EID: 20444493148     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084596     Document Type: Article

References (12)

1. Mathews REF: Classification and nomenclature of viruses. Intervirology 1982;17:1-15.
2. Strohmaier K, Franze R, Adam KH: Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 1982;59:295-306.
3. Benvenisti L, Rogel A, Kuznetzova L, Bujanover S, Becker Y, Stram Y: Gene gun-mediated DNA vaccination against foot-and-mouth disease virus. Vaccine 2001;19:3885-3895.
4. Wong HT, Cheng SCS, Sin FWY, Chen EWC, Xie YA: A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 2002;20:2641-2647.
5. Mak NK, Leung CY, Wei XY, Shen XL, Wong RNS, Leung KN, Fung MC: Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochem Pharmacol 2004;67:167-174.
6. Kunikata T, Tatefuji T, Aga H, Iwaki K, Ikeda M, Kurimoto M: Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol 2000;410:93-100.
7. Smbrool J, Fritsch F, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, 1989.
8. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F: Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 1987;330:381-384.
9. Carrillo C, Wigdorovitz A, Oliveros JC: Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J Virol 1998;72:1688-1690.
10. Sobrino F, Blanco E, Garcia-Briones M, Ley V: Synthetic peptide vaccines: Foot-and-mouth disease virus as a model. Dev Biol Standard, 1999;101:39-43.
11. Liu YH: Studies on the antiendotoxic action of Radix isatidis. J China Pharmaceutical University 1995;26:297-299.
12. Li GJ, Yan WY, Xu QX, Sheng ZT, Zheng ZX: Study on the DNA vaccine against foot-and-mouth disease virus using the heavy chain constant region of swine IgG as the carrier for peptide epitopes. Chin J Bioechnol 2001;17:322-324.